Adam Margolin, NextVivo CEO
Fledgling Stanford spinout promising 3D models of fully human tissue wins the backing of some big-time investors
When conducting preclinical tests in drug development, researchers have for years used different kinds of animal models, from mice to nonhuman primates. But what if …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
